Promoted For
Local Shares

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Updated
Dr. Reddy's Laboratories Limited is a drug manufacturers-specialty & generic business based in the US. DrReddys Laboratories shares (RDY) are listed on the NYSE and all prices are listed in US Dollars. DrReddys Laboratories employs 21,650 staff and has a market cap (total outstanding shares value) of USD$10.1 billion.
Promoted For
Local Shares
Promoted For
Cheap Broker Fees
Promoted For
Overall Trading Platform
52-week range | USD$33.1177 - USD$73.39 |
---|---|
50-day moving average | USD$65.1053 |
200-day moving average | USD$65.9104 |
Wall St. target price | USD$72.5 |
PE ratio | 43.4473 |
Dividend yield | USD$0.292 (0.48%) |
Earnings per share (TTM) | USD$1.404 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the last close of $N/A
1 week (2021-02-24) | N/A |
---|---|
1 month (2021-02-03) | N/A |
3 months (2020-12-03) | N/A |
6 months (2020-09-03) | N/A |
1 year (2020-03-03) | N/A |
---|---|
2 years (2019-03-03) | N/A |
3 years (2018-03-03) | N/A |
5 years (2016-03-03) | N/A |
Valuing DrReddys Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DrReddys Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
DrReddys Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, DrReddys Laboratories shares trade at around 43x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
DrReddys Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0915. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DrReddys Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Gross profit TTM | USD$94 billion |
---|---|
Return on assets TTM | 8.56% |
Return on equity TTM | 13.37% |
Profit margin | 11.38% |
Book value | $11.575 |
Market capitalisation | USD$10.1 billion |
TTM: trailing 12 months
There are currently 1.2 million DrReddys Laboratories shares held short by investors – that's known as DrReddys Laboratories's "short interest". This figure is 4.4% up from 1.1 million last month.
There are a few different ways that this level of interest in shorting DrReddys Laboratories shares can be evaluated.
DrReddys Laboratories's "short interest ratio" (SIR) is the quantity of DrReddys Laboratories shares currently shorted divided by the average quantity of DrReddys Laboratories shares traded daily (recently around 224709.14396887). DrReddys Laboratories's SIR currently stands at 5.14. In other words for every 100,000 DrReddys Laboratories shares traded daily on the market, roughly 5140 shares are currently held short.
However DrReddys Laboratories's short interest can also be evaluated against the total number of DrReddys Laboratories shares, or, against the total number of tradable DrReddys Laboratories shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case DrReddys Laboratories's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 DrReddys Laboratories shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable DrReddys Laboratories shares, roughly 0 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against DrReddys Laboratories.
Ever wondered how to buy shares in Blue Apron? We explain how and compare a range of providers that can give you access to many brands, including Blue Apron.
Ever wondered how to buy shares in Kandi? We explain how and compare a range of providers that can give you access to many brands, including Kandi.
Ever wondered how to buy shares in B&G Foods? We explain how and compare a range of providers that can give you access to many brands, including B&G Foods.
Ever wondered how to buy shares in Ayro? We explain how and compare a range of providers that can give you access to many brands, including Ayro.
Ever wondered how to buy shares in The Children’s Place? We explain how and compare a range of providers that can give you access to many brands, including The Children’s Place.
Ever wondered how to buy shares in Tanger Factory Outlet Centers? We explain how and compare a range of providers that can give you access to many brands, including Tanger Factory Outlet Centers.
Ever wondered how to buy shares in Blockbuster? We explain how and compare a range of providers that can give you access to many brands, including Blockbuster.
Ever wondered how to buy shares in Ligand Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Ligand Pharmaceuticals.
Steps to owning and managing SNDL, with 24-hour and historical pricing before you buy.
Steps to owning and managing KOSS, with 24-hour and historical pricing before you buy.